SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 01/01/2018 | 3. Issuer Name and Ticker or Trading Symbol Strongbridge Biopharma plc [ SBBP ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Ordinary Shares | 22,062(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (Right to Buy) | (2) | 05/26/2025 | Common Stock | 18,181 | 15.71 | D | |
Stock Option (Right to Buy) | (3) | 05/26/2025 | Common Stock | 18,181 | 15.71 | D | |
Stock Option (Right to Buy) | (4) | 05/26/2025 | Common Stock | 9,091 | 15.71 | D | |
Stock Option (Right to Buy) | (5) | 05/26/2025 | Common Stock | 9,092 | 15.71 | D | |
Stock Option (Right to Buy) | (6) | 07/21/2020 | Common Stock | 133,363 | 18.8 | D | |
Stock Option (Right to Buy) | (7) | 02/26/2026 | Common Stock | 65,000 | 3.94 | D | |
Stock Option (Right to Buy) | (8) | 02/23/2027 | Common Stock | 180,000 | 2.9 | D |
Explanation of Responses: |
1. Of the 22,062 shares reported as directly held, 20,000 are restricted stock units. |
2. This option vests in sixteen equal quarterly installments beginning August 26, 2015. |
3. This option vests in sixteen equal quarterly installments beginning October 16, 2015. |
4. This option becomes 100% exercisable on the date that is the last trading day in the period in which the Issuer's closing stock price on each of 20 consecutive trading days as reported on NASDAQ has been at least $33.66, provided this occurs on or before May 26, 2019. |
5. This option becomes 100% exercisable on the date that is the one year anniversary of the date that is the last trading day in the period in which the Issuer's closing stock price on each of 20 consecutive trading days as reported on NASDAQ has been at least $33.66, provided this occurs on or before May 26, 2019. |
6. This option vests in three equal annual installments beginning March 23,2016. |
7. This option vests in sixteen equal quarterly installments beginning May 26,2016. |
8. This option vests in sixteen equal quarterly installments beginning May 23, 2017. |
Remarks: |
Exhibit List: Exhibit 24 - Power of Attorney |
/s/ Stephen J. Long, as attorney-in-fact | 01/02/2018 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |